SUNNYVALE, Calif., Jan. 7 /PRNewswire/ --
Molecular Devices Corporation (Nasdaq: MDCC) a leader in innovative solutions
for drug discovery and life sciences research, today announced that
Joseph D. Keegan, Ph.D., CEO and President, will present at the JPMorgan H&Q
20th Annual Healthcare Conference on Wednesday, January 9, 2002 beginning at
11:30 a.m. (PST), at The Westin St. Francis Hotel in San Francisco.
Molecular Devices' presentation will be webcast live, over the internet,
at http://www.moleculardevices.com. The presentation will be archived on the
Company's website for 5 days.
Molecular Devices Corporation is a leading supplier of high-performance
bioanalytical measurement systems that accelerate and improve drug discovery
and other life sciences research. Molecular Devices' systems and consumables
enable pharmaceutical and biotechnology companies to leverage advances in
genomics and combinatorial chemistry by facilitating the high-throughput and
cost-effective identification and evaluation of drug candidates. Molecular
Devices' solutions are based on its advanced core technologies that integrate
its expertise in engineering, molecular and cell biology, and chemistry.
Molecular Devices enables its customers to improve research productivity and
effectiveness, which ultimately accelerates the complex process of discovering
and developing new drugs.
SOURCE Molecular Devices Corporation
 back to top
Related links:
http://www.moldev.com
CONTACT:
Tim Harkness of Molecular Devices
Corporation, +1-408-747-3533
|
